References
- Gustafsson CM, Falkenberg M, Larsson NG. Maintenance and expression of mammalian mitochondrial DNA. Annu Rev Biochem. 2016;85:133–160.
- DiMauro S, Schon EA. Mitochondrial respiratory-chain diseases. N Engl J Med. 2003;348(26):2656–2668.
- Rao M, Li L, Demello C, et al. Mitochondrial DNA injury and mortality in hemodialysis patients. J Am Soc Nephrol. 2009;20(1):189–196.
- Fazzini F, Lamina C, Fendt L, et al. Mitochondrial DNA copy number is associated with mortality and infections in a large cohort of patients with chronic kidney disease. Kidney Int. 2019;96(2):480–488.
- Rodrigues JC, Haas M, Reich HN. IgA nephropathy. Clin J Am Soc Nephrol. 2017;12(4):677–686.
- Nunnari J, Suomalainen A. Mitochondria: in sickness and in health. Cell. 2012;148(6):1145–1159.
- Malik AN, Czajka A. Is mitochondrial DNA content a potential biomarker of mitochondrial dysfunction? Mitochondrion. 2013;13(5):481–492.
- Czajka A, Ajaz S, Gnudi L, et al. Altered mitochondrial function, mitochondrial DNA and reduced metabolic flexibility in patients with diabetic nephropathy. EBioMedicine. 2015;2(6):499–512.
- Tin A, Grams ME, Ashar FN, et al. Association between mitochondrial DNA copy number in peripheral blood and incident CKD in the Atherosclerosis Risk in Communities study. J Am Soc Nephrol. 2016;27(8):2467–2473.
- Lee JE, Park H, Ju YS, et al. Higher mitochondrial DNA copy number is associated with lower prevalence of microalbuminuria. Exp Mol Med. 2009;41(4):253–258.
- Roberts IS. Pathology of IgA nephropathy. Nat Rev Nephrol. 2014;10(8):445–454.
- Shibano T, Takagi N, Maekawa K, et al. Epidemiological survey and clinical investigation of pediatric IgA nephropathy. Clin Exp Nephrol. 2016;20(1):111–117.
- Jarrick S, Lundberg S, Welander A, et al. Mortality in IgA nephropathy: a nationwide population-based cohort study. J Am Soc Nephrol. 2019;30(5):866–876.
- Moriyama T. Clinical and histological features and therapeutic strategies for IgA nephropathy. Clin Exp Nephrol. 2019;23(9):1089–1099.
- Hotta O, Miyazaki M, Furuta T, et al. Tonsillectomy and steroid pulse therapy significantly impact on clinical remission in patients with IgA nephropathy. Am J Kidney Dis. 2001;38(4):736–743.
- Bjorneklett R, Vikse BE, Bostad L, et al. Long-term risk of ESRD in IgAN; validation of Japanese prognostic model in a Norwegian cohort. Nephrol Dial Transplant. 2012;27(4):1485–1491.
- Trimarchi H, Barratt J, Cattran DC, et al. Oxford classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group. Kidney Int. 2017;91(5):1014–1021.
- Sharma P, Sampath H. Mitochondrial DNA integrity: role in health and disease. Cells. 2019;8(2):100.
- Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612.
- Ashar FN, Moes A, Moore AZ, et al. Association of mitochondrial DNA levels with frailty and all-cause mortality. J Mol Med. 2015;93(2):177–186.
- Williams D, Davison J. Chronic kidney disease in pregnancy. BMJ. 2008;336(7637):211–215.
- He WJ, Li C, Huang Z, et al. Association of mitochondrial DNA copy number with risk of progression of kidney disease. Clin J Am Soc Nephrol. 2022;17(7):966–975.
- Yu BC, Cho N-J, Park S, et al. IgA nephropathy is associated with elevated urinary mitochondrial DNA copy numbers. Sci Rep. 2019;9(1):16068.
- Castellani CA, Longchamps RJ, Sun J, et al. Thinking outside the nucleus: mitochondrial DNA copy number in health and disease. Mitochondrion. 2020;53:214–223.
- Zhang X, Agborbesong E, Li X. The role of mitochondria in acute kidney injury and chronic kidney disease and its therapeutic potential. Int J Mol Sci. 2021;22(20):11253.
- Galvan DL, Green NH, Danesh FR. The hallmarks of mitochondrial dysfunction in chronic kidney disease. Kidney Int. 2017;92(5):1051–1057.
- Koller A, Fazzini F, Lamina C, et al. Mitochondrial DNA copy number is associated with all-cause mortality and cardiovascular events in patients with peripheral arterial disease. J Intern Med. 2020;287(5):569–579.